Since VEGF has been shown to block DC differentiation and maturation inpreclinical models, high levels of VEGF in cancer patients may induce anaccumulation of immature and functionally impaired DC contributing to tumorescape from immunosurveillance. The gene discussed is VEGFA; the disease is cancer.